Improving Symptoms and Outcomes in a 68 year-old woman with Symptomatic Systolic HF is organized by American College of Cardiology (ACC).
Date of Release: August 1, 2022
Term of Approval/Date of Expiration: July 31, 2025
Gain insights on the practical components of SGLT2is including patient selection, initiation, dosing, sequencing, and monitoring to successfully incorporate these agents into practice.
Upon completion of this activity, you should be able to:
• Identify the clinical indications and key considerations for the selection of SGLT2 inhibitors for heart failure patients
• Establish a contemporary prescribing timeline including initiation, dosing, and monitoring of SGLT2 inhibitors?
Additional details will be posted as soon as information is available.